Patents by Inventor Dunja Van Oyen

Dunja Van Oyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosis of primary hyperaldosteronism
    Patent number: 10295552
    Abstract: Methods and kits for the diagnosis of primary hyperaldosteronism (PHA). In particular, the present invention relates to the use of a new diagnostic parameter that is composed of the ratio between the Ang II level, in particular the steady state equilibrium Ang II level, and the aldosterone level in a biological sample, such as e.g. plasma. The ratio of the two measured parameters is used to diagnose PHA in patients and has clear advantages over currently used diagnostic methods.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: May 21, 2019
    Assignee: ATTOQUANT DIAGNOSTICS GMBH
    Inventors: Marko Poglitsch, Cornelia Schwager, Dunja Van Oyen, Martin Leitner
  • METHOD FOR DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM
    Publication number: 20180164330
    Abstract: Methods and kits for the diagnosis of primary hyperaldosteronism (PHA). In particular, the present invention relates to the use of a new diagnostic parameter that is composed of the ratio between the Ang II level, in particular the steady state equilibrium Ang II level, and the aldosterone level in a biological sample, such as e.g. plasma. The ratio of the two measured parameters is used to diagnose PHA in patients and has clear advantages over currently used diagnostic methods.
    Type: Application
    Filed: October 20, 2017
    Publication date: June 14, 2018
    Applicant: ATTOQUANT DIAGNOSTICS GMBH
    Inventors: Marko POGLITSCH, Cornelia SCHWAGER, Dunja VAN OYEN, Martin LEITNER
  • Method for diagnosis of primary hyperaldosteronism
    Patent number: 9829496
    Abstract: Methods and kits for the diagnosis of primary hyperaldosteronism (PHA). In particular, the use of a new diagnostic parameter that is composed of the ratio between the Ang II level, in particular the steady state equilibrium Ang II level, and the aldosterone level in a biological sample, such as e.g. plasma. The ratio of the two measured parameters is used to diagnose PHA in patients and has clear advantages over currently used diagnostic methods.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: November 28, 2017
    Assignee: ATTOQUANT DIAGNOSTICS GMBH
    Inventors: Marko Poglitsch, Cornelia Schwager, Dunja Van Oyen, Martin Leitner
  • METHOD FOR DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM
    Publication number: 20160266151
    Abstract: The present invention relates to methods and kits for the diagnosis of primary hyperaldosteronism (PHA). In particular, the present invention relates to the use of a new diagnostic parameter that is composed of the ratio between the Ang II level, in particular the steady state equilibrium Ang II level, and the aldosterone level in a biological sample, such as e.g. plasma. The ratio of the two measured parameters is used to diagnose PHA in patients and has clear advantages over currently used diagnostic methods.
    Type: Application
    Filed: October 17, 2014
    Publication date: September 15, 2016
    Applicant: ATTOQUANT DIAGNOSTICS GMBH
    Inventors: Marko Poglitsch, Cornelia Schwager, Dunja Van Oyen, Martin Leitner